Author: Zhu, Yue; Zhu, Rongjia; Liu, Kun; Li, Xin; Chen, Dezhong; Bai, Dunyao; Luo, Jieli; Liu, Yixun; Zhang, Yan; Li, Li; Hu, Junfang; Xu, Dayong; Liu, Yan; Zhao, Robert Chunhua
Title: Human Umbilical Cord Mesenchymal Stem Cells for Adjuvant Treatment of a Critically Ill COVID-19 Patient: A Case Report Cord-id: 8pjcakf6 Document date: 2020_9_28
ID: 8pjcakf6
Snippet: BACKGROUND: COVID-19 (coronavirus disease 2019) has become a global public health emergency since patients were first detected in Wuhan, China, in December 2019. Currently, there are no satisfying antiviral medications and vaccines available. CASE PRESENTATION: We reported the treatment process and clinical outcome of a 48-year-old man critically ill COVID-19 patient who received transfusion of allogenic human umbilical cord mesenchymal stem cells (UC-MSCs). CONCLUSIONS: We proposed that UC-MSC
Document: BACKGROUND: COVID-19 (coronavirus disease 2019) has become a global public health emergency since patients were first detected in Wuhan, China, in December 2019. Currently, there are no satisfying antiviral medications and vaccines available. CASE PRESENTATION: We reported the treatment process and clinical outcome of a 48-year-old man critically ill COVID-19 patient who received transfusion of allogenic human umbilical cord mesenchymal stem cells (UC-MSCs). CONCLUSIONS: We proposed that UC-MSC transfusion might be a new option for critically ill COVID-19. Although only one case we were shown, more similar clinical cases are inquired for further evidence providing the potential effectiveness of UC-MSC treatment.
Search related documents:
Co phrase search for related documents- abnormal level and lung disease: 1
- abnormal level and lung function: 1
- abnormal level and lung injury: 1
- absolute number and acute lung injury: 1
- absolute number and acute respiratory distress: 1, 2, 3, 4
- absolute number and adjuvant treatment: 1
- absolute number and lung disease: 1
- absolute number and lung function: 1
- absolute number and lung injury: 1
- absolute number and lymphocyte absolute number: 1, 2, 3, 4, 5, 6, 7
- acute lung injury and adjuvant treatment: 1, 2
- acute lung injury and low immunogenicity: 1, 2
- acute lung injury and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute lung injury and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute lung injury and lung inflammatory cell recruitment: 1
- acute lung injury and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute lung injury cause and lung disease: 1, 2, 3, 4, 5, 6
- acute lung injury cause and lung function: 1, 2, 3, 4
- acute lung injury cause and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
Co phrase search for related documents, hyperlinks ordered by date